JULIE EDWARDS: Open Payments
NPI 1538828124 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 32 payments from 12 companies in 2025. Trend: 2023 $605 · 2024 $643 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $286 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Novo Nordisk Inc | 3 | $52 |
| Boston Scientific Corporation | 1 | $17 |
| Ascensia Diabetes Care Us Inc. | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Gilead Sciences, Inc. | 1 | $15 |
| Organon LLC | 1 | $15 |
Products named: VRAYLAR, QULIPTA, Auvelity, UBRELVY, Wegovy, WaveWriter Alpha Prime 16, INSPIRE, ROTATEQ.
Industry payments across UT — which companies pay providers there.
